Latest filing published 09 Nov 2023 for Lexeo Therapeutics, Inc., €4.7M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +493.5%Entry US$7.28 · Close at T+365 US$43.21
- -73.2%Entry US$22.82 · Close at T+365 US$6.11
- +7.9%Entry US$15.26 · Close at T+365 US$16.46
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Longitude Capital Partners IV, LLC: trading record in brief
Longitude Capital Partners IV, LLC is a declared insider at 2 companies; the most frequent names are Vera Therapeutics, Inc. and Lexeo Therapeutics, Inc. In total, 7 filings cover trades dated from 18 May 2021 to 7 November 2023.
Every open-market trade on record is a purchase: 4 purchases worth €28.3M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2023: 2 purchases and no sales on the market.
In size, the median ticket on the buying side is €6.4M. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 3 purchases show a median change of +5.8%, with the price up in 67% of them. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 9 November 2023: an open-market purchase of €4.7M, in Lexeo Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Longitude Capital Partners IV, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ▲
Same trade as the filing by Omega Fund VI, L.P., counted once
5M USD28SEC454,545 shares@ US$11.00100.0% of flowCommon StockSEC:0001209191-23-054904:2Canonical exit: 5 Feb 2024 (T+90) - 319,126 sharesCommon StockSEC:0001209191-23-054904:1
- 1,793,429 sharesCommon StockSEC:0001209191-23-054904:0
- 1,714,285 shares@ US$7.0071.8% of flowClass A Common StockSEC:0000899243-23-004349:0Canonical exit: 7 May 2023 (T+90)
- 333,333 shares@ US$15.0028.2% of flowClass A Common StockSEC:0000899243-22-013598:0Canonical exit: 11 May 2022 (T+90)
- 909,090 shares@ US$11.0034.5% of flowClass A Common StockSEC:0001209191-21-033816:1Canonical exit: 16 Aug 2021 (T+90)
- 2,187,504 sharesClass A Common StockSEC:0001209191-21-033816:0
7 of 6 declarations
